江中药业：12月29日召开董事会会议

Group 1 - Jiangzhong Pharmaceutical (SH 600750) announced the convening of its 11th meeting of the 10th Board of Directors on December 29, 2025, to discuss the appointment of a new general manager [1] - For the first half of 2025, Jiangzhong Pharmaceutical's revenue composition was as follows: pharmaceutical industry accounted for 99.64%, liquor industry 0.25%, and other businesses 0.11% [1] - As of the report date, Jiangzhong Pharmaceutical's market capitalization was 15 billion yuan [1] Group 2 - A new type of chip has been developed in China, which bypasses the restrictions on lithography machines and supports AI training and embodied intelligence, capable of mass production using mature processes of 28 nanometers and above [1]